1Miceli-Richard C,Dougados M.Leflmmmide for the treatment of rheumatoid arthritis[J].Expert Opin Phamacother,2003,4(6):987-997.
2Urushibarn M,Takayarnagi H,Koga T,et al.The antirheumatic drug leflunmide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells[ J ].Arthritis Rheum,2004,50 (3):794-804.
3Dimitrona,P,Skapenko A,Schleyerbach,R et al.Immu-modulatory functions of leflunomide:inhibition of T helper(Th1) cell activation and promotion of Th2 differentiation[J].Arthritis Rheuma,2001,44(9):216-221.
5Chow KM,Szeto CC.Leflunomide and antiglomerular membrane basement glomerulonephritis:commen on the letter by Bruyn[ J ].Arthritis Rheum,2004,50(1):336-337.
8Ogawa T,Inazu M,Gotoh K,et al.Effects of leflunomide on glomerulonephritis induced by antibasement membrane antibody in rat[ J ].Agents Actions,1990,31 (3 -4):321-328.
9Ogawa T,Inazu M,Gotoh K,et al.Therapeutic effects of leflunomide:a new antirheumatic drug on glomerulonephritis induced by antibasement membrane antibody in rats[ J ].Clin Immunol Immunopathol,1991,61(1):103-118.
10Pavenstadt H,Kriz W,Kretzler M et al.Cell biology of the glomerular podocyte[ J].Physiol Rev,2003,83(1):253-307.
